Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.
about
Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegiaDelving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosologySulphatation does not appear to be a protective mechanism to prevent oxysterol accumulation in humans and miceLipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosusGenetic connections between neurological disorders and cholesterol metabolismThe endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.Cholesterol in brain disease: sometimes determinant and frequently implicated.27-Hydroxycholesterol: the first identified endogenous SERMMarked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutationCholestenoic acids regulate motor neuron survival via liver X receptors.Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegiaHydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia.Mutations in phospholipase DDHD2 cause autosomal recessive hereditary spastic paraplegia (SPG54).De novo synthesis of steroids and oxysterols in adipocytesCellular pathways of hereditary spastic paraplegia.Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation.Functional mutation analysis provides evidence for a role of REEP1 in lipid droplet biology.Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways.25-Hydroxycholesterol regulates cholesterol homeostasis in the murine CATH.a neuronal cell line.Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue.Somatosensory conduction pathway in spastic paraplegia type 5.The EBI2 signalling pathway plays a role in cellular crosstalk between astrocytes and macrophages.Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanismCYP7B1: novel mutations and magnetic resonance spectroscopy abnormalities in hereditary spastic paraplegia type 5A.EBI2 receptor regulates myelin development and inhibits LPC-induced demyelination.Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.27-Hydroxycholesterol stimulates cell proliferation and resistance to docetaxel-induced apoptosis in prostate epithelial cells.Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations.
P2860
Q24310003-23D21631-0061-436B-B11B-C64B89B90C5EQ28081453-4F985794-F159-44E8-B139-3045AD15C853Q28534492-EC97E444-5A26-47AF-B6DC-F4F2129ADF2FQ30588683-8D6FA303-AF29-423F-A56C-E6022CCD04BFQ34053056-88202FFB-61A1-433A-877E-674F8180EC95Q34132498-B317DA9A-CE49-4840-B8A4-84F900AA2C7FQ34313405-AFD53C60-0995-4983-AC19-1609711BE778Q34621446-3C140C63-8E9B-4265-A920-E65081E7117FQ34762182-4F9254D3-7C0E-40F1-A685-6BFB559F8758Q34776197-09C1FCD5-E15E-4E31-8B26-87B2559C95D0Q35140077-F37F4148-A6C7-48AF-A132-F1D8824EEF22Q36008185-93DAE897-5B52-42CF-8028-385A33BB3A8CQ36220053-F680AC38-7CB1-4068-944A-F0DAE0F0861FQ37010397-191E2D34-E459-4F1E-AA3D-0A75A41AA2F2Q37235147-A5953675-140C-473C-A459-464C69FF10C7Q37459292-4CF8376F-E5DE-479E-A8F3-8309B3497DEBQ38006054-68B99E06-48A7-4801-878A-BA28F64EDC80Q38973023-1529292C-7DF1-4392-B76E-9706D0F8BF25Q39029111-3F41E534-3AA4-4514-94AF-22F8BED18827Q39134814-DAA5CB08-FE69-4A66-8487-82BC3A6C0D2EQ39205339-1DE6CC05-C8AC-4225-999E-8CA722DA98A3Q40536177-05CDB35D-B988-46A0-80C3-96C964AE58E7Q41942827-4CCDDE78-C836-44FF-9874-F5DEC6CFD19CQ42795370-6F68D1E1-47FC-4DFD-B94A-5129338EE97DQ42821910-FB7AF341-DE2B-4B66-9C0C-4648BCB5B687Q44462451-B8E4A2C5-771D-4692-9434-101B3198F54AQ47167898-91810BBA-A61E-4131-985D-6245C57B638CQ47416181-FF5ECFA2-E507-437E-BC67-047FDB084A58Q47922188-8094B6E6-C855-466C-B289-41D37D6EB900Q48067038-3434B98B-1E47-4843-9949-096DEF0EEEF8Q50335717-DD2B6B91-53FF-4919-B80A-C65CF104E6DF
P2860
Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Marked accumulation of 27-hydr ...... th hereditary spastic paresis.
@ast
Marked accumulation of 27-hydr ...... th hereditary spastic paresis.
@en
type
label
Marked accumulation of 27-hydr ...... th hereditary spastic paresis.
@ast
Marked accumulation of 27-hydr ...... th hereditary spastic paresis.
@en
prefLabel
Marked accumulation of 27-hydr ...... th hereditary spastic paresis.
@ast
Marked accumulation of 27-hydr ...... th hereditary spastic paresis.
@en
P2093
P2860
P50
P356
P1476
Marked accumulation of 27-hydr ...... th hereditary spastic paresis.
@en
P2093
Han-Xiang Deng
Magnus Hansson
Nailah Siddique
Ricardo E Madrid
Sandra Donkervoort
Teepu Siddique
P2860
P304
P356
10.1194/JLR.M002543
P577
2009-10-07T00:00:00Z